重组沙眼衣原体MOMP疫苗在小鼠中诱导跨血清型保护
本研究用沙眼衣原体D型重组主要外膜蛋白(rMOMP)疫苗经黏膜和系统途径免疫雌性C3H/HeN小鼠,佐剂为CpG-1826和Montanide ISA 720,随后卵巢囊内攻击不同血清型。疫苗对同一复合体内的D和E血清型诱导保护,减少阴道排菌和不孕,但对不同亚复合体的F血清型无保护。
要点
- rMOMP疫苗可减少同复合体血清型攻击后的阴道排菌。
- 疫苗保护生育力并减少输卵管积水,但对F血清型无效。
- 免疫应答与攻击血清型的亲缘关系相关。
核心结论
- 重组沙眼衣原体rMOMP疫苗首次在小鼠中展示对感染、病理和不孕的跨血清型保护。
研究设计与样本
- 雌性C3H/HeN小鼠经黏膜和系统途径接种D型rMOMP疫苗,佐剂为CpG-1826和Montanide ISA 720,卵巢囊内攻击D、E或F血清型。
主要发现
- 疫苗对同一复合体的D和E血清型攻击有保护,对F血清型无保护。
- 保护依据包括阴道培养阳性鼠数、阳性培养数、回收包涵体形成单位和培养阳性天数。
- 基于生育率、胚胎数和输卵管积水形成,疫苗对D和E血清型攻击有保护,对F血清型无保护。
临床怎么用
- 提示rMOMP疫苗候选策略需考虑血清型亲缘关系对交叉保护的影响。
局限性
- 研究为小鼠模型,结果不能直接外推至人类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen worldwide. Here, we determined the ability of a C. trachomatis recombinant major outer membrane protein (rMOMP) vaccine to elicit cross-serogroup protection. METHODS: Female C3H/HeN mice were vaccinated by mucosal and systemic routes with C. trachomatis serovar D (UW-3/Cx) rMOMP and challenged in the ovarian bursa with serovars D (UW-3/Cx), D (UCI-96/Cx), E (IOL-43), or F (N.I.1). CpG-1826 and Montanide ISA 720 were used as adjuvants. RESULTS: Immune responses following vaccination were more robust against the most closely related serovars. Following a genital challenge (as determined by number of mice with positive vaginal cultures, number of positive cultures, number of inclusion forming units recovered, and number of days with positive cultures) mice challenged with C. trachomatis serovars of the same complex were protected but not those challenged with serovar F (N.I.1) from a different subcomplex. Females were caged with male mice. Based on fertility rates, number of embryos, and hydrosalpinx formation, vaccinated mice were protected against challenges with serovars D (UW-3/Cx), D (UCI-96/Cx), and E (IOL-43) but not F (N.I.1). CONCLUSIONS: This is the first subunit vaccine shown to protect mice against infection, pathology, and infertility caused by different C. trachomatis serovars.
引用
- Tifrea DF, Pal S, de la Maza LM, et al. A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility. J Infect Dis. 2020. PMID: 31504647. doi:10.1093/infdis/jiz438
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。